Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Scaffold-based strategies show promise for regenerating hair follicles and teeth but need more research for clinical use.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

Smart hydrogel dressings could improve diabetic wound healing by adjusting to wound conditions and controlling drug release.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Current methods can't fully recreate skin and its features, and more research is needed for clinical use.

The document concludes that more research is needed on making and understanding biomaterial scaffolds for wound healing.

Melanocytes from human fetal hair follicles were successfully cultured, showing potential for hair disease research and clinical use.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New technologies show potential for better understanding and treating skin conditions with abnormal mucin, but more research is needed for clinical use.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

3D bioprinting is advancing in plastic and reconstructive surgery, especially for creating tissues and improving surgical planning, but faces challenges like vascularization and material development.

Microneedles are being used and tested for various medical and cosmetic treatments.

Fetal cells could improve skin repair with minimal scarring and are a potential ready-to-use solution for tissue engineering.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

PRP use in skin care and plastic surgery is growing, especially in the U.S. and Italy.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Human pluripotent stem cells could be used to make platelets for medical use, but safety, effectiveness, and cost issues need to be resolved.

Biologicals are increasingly used in medicine and cosmetics, especially for skin and hair treatments, but more research is needed.